Paper28102473
The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter.
Sun Y and 3 others. Mol Neurobiol, 2018. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter. Papers, record 28102473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28102473
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Ischemia | Major topic |
| Cell Death | Major topic |
| Cell Survival | Major topic |
| Neurons | Major topic |
| Receptors, N-Methyl-D-Aspartate | Major topic |
| Animals | |
| Humans | |
| Signal Transduction |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19141074 | Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity. | J Neurochem | 2009 | https://conductscience.org/library/papers/19141074 | PubMed |
| 2 | 14976517 | MAPK cascade signalling and synaptic plasticity. | Nat Rev Neurosci | 2004 | https://conductscience.org/library/papers/14976517 | PubMed |
| 3 | 21554958 | Elevation of p-NR2A(S1232) by Cdk5/p35 contributes to retinal ganglion cell apoptosis in a rat experimental glaucoma model. | Neurobiol Dis | 2011 | https://conductscience.org/library/papers/21554958 | PubMed |
| 4 | 19482936 | Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19482936 | PubMed |
| 5 | 21102461 | Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. | Nat Med | 2010 | https://conductscience.org/library/papers/21102461 | PubMed |
| 6 | 26809997 | Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. | Prog Mol Biol Transl Sci | 2016 | https://conductscience.org/library/papers/26809997 | PubMed |
| 7 | 7683048 | Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. | J Neurosci | 1993 | https://conductscience.org/library/papers/7683048 | PubMed |
| 8 | 12849400 | Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? | Lancet Neurol | 2002 | https://conductscience.org/library/papers/12849400 | PubMed |
| 9 | 26919761 | Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design. | J Med Chem | 2016 | https://conductscience.org/library/papers/26919761 | PubMed |
| 10 | 23839940 | Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23839940 | PubMed |
| 11 | 11786882 | Future of neuroprotective drugs in doubt. | Nat Med | 2002 | https://conductscience.org/library/papers/11786882 | PubMed |
| 12 | 16540573 | Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. | J Neurosci | 2006 | https://conductscience.org/library/papers/16540573 | PubMed |
| 13 | 25139875 | Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke. | Stroke | 2014 | https://conductscience.org/library/papers/25139875 | PubMed |
| 14 | 14720220 | NR2A induction and NMDA receptor-dependent neuronal death by neurotrophin-4/5 in cortical cell culture. | J Neurochem | 2004 | https://conductscience.org/library/papers/14720220 | PubMed |
| 15 | 20141836 | DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. | Cell | 2010 | https://conductscience.org/library/papers/20141836 | PubMed |
| 16 | 18022328 | Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. | Neuroscience | 2007 | https://conductscience.org/library/papers/18022328 | PubMed |
| 17 | 21685929 | CaMKII in cerebral ischemia. | Acta Pharmacol Sin | 2011 | https://conductscience.org/library/papers/21685929 | PubMed |
| 18 | 21135846 | Fashioning drugs for stroke. | Nat Med | 2010 | https://conductscience.org/library/papers/21135846 | PubMed |
| 19 | 10837912 | N-Methyl-D-aspartate receptor mediated toxicity in nonneuronal cell lines: characterization using fluorescent measures of cell viability and reactive oxygen species production. | Brain Res Mol Brain Res | 2000 | https://conductscience.org/library/papers/10837912 | PubMed |
| 20 | 14556939 | Possible mechanisms underlying the protective effects of SY-21, an extract of a traditional Chinese herb, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampus. | Brain Res | 2003 | https://conductscience.org/library/papers/14556939 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42201999 | State-specific inhibition of NMDA receptors by memantine provides insight into NMDAR channel blocker tolerability. | Sci Adv | 2026 | https://conductscience.org/library/papers/42201999 | PubMed |
| 41188625 | New advances in small molecule drugs targeting NMDA receptors. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41188625 | PubMed |
| 38799621 | Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38799621 | PubMed |
| 38004401 | GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38004401 | PubMed |
| 37845379 | The NR2B-targeted intervention alleviates the neuronal injuries at the sub-acute stage of cerebral ischemia: an exploration of stage-dependent strategy against ischemic insults. | Exp Brain Res | 2023 | https://conductscience.org/library/papers/37845379 | PubMed |
| 36009192 | The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36009192 | PubMed |
| 35628606 | The Development of Novel Drug Treatments for Stroke Patients: A Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628606 | PubMed |
| 34978648 | Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators. | Cell Mol Neurobiol | 2023 | https://conductscience.org/library/papers/34978648 | PubMed |
| 33692666 | Icaritin Alleviates Glutamate-Induced Neuronal Damage by Inactivating GluN2B-Containing NMDARs Through the ERK/DAPK1 Pathway. | Front Neurosci | 2021 | https://conductscience.org/library/papers/33692666 | PubMed |
| 31105534 | Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31105534 | PubMed |
| 29948728 | Neuroprotection of Cytisine Against Cerebral Ischemia-Reperfusion Injury in Mice by Regulating NR2B-ERK/CREB Signal Pathway. | Neurochem Res | 2018 | https://conductscience.org/library/papers/29948728 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GRIN2A | 2903 | PubTator's text mining | https://conductscience.org/library/genes/2903 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28102473
GET https://conductscience.org/api/papers/v1/28102473/references?page=2